TP53 and cancer: Differentially expressed, enriched miRNAs from HLCs compared to hepatocytes control fatty acid biosynthesis and metabolism, ECM-receptor interaction, proteoglycans in cancer, Hippo signaling pathway, adherens junction, lysine degradation, prion diseases, viral carcinogenesis, pathways in cancer, p53 signaling pathway, and cell cycle.